TherapeuticsMD wins FDA nod for hormone therapy, capping off drugmaker's prolific year
The FDA has approved TherapeuticsMD’s $TXMD hormone therapy for hot flashes associated with menopause, marking the women’s health drugmaker’s third approval this year.
Bijuva, which …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
